Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14847 total
Western Alliance Bancorporation heads into its October 16 earnings date with short interest climbing, analyst targets trimming, and the Street debating whether credit quality progress can outpace a deteriorating…
The Invesco Semiconductors ETF PSI enters October with its most aggressive short-side build in months, even as the fund itself has quietly posted a 15% gain over the past month. The dominant story this week is how fast…
IGPT, Invesco's AI and Next Gen Software ETF, ends the week with a notably different texture from the extreme call-dominated setup that drove the prior two notes: short interest has surged, borrowing costs have…
MORN enters its October earnings window down 14% over the past month, with options markets showing the most defensive tilt in weeks and the stock lagging well behind its financial data peers. The options picture is the…
Huntsman Corporation enters the final session of September with its shares down 7.4% on the week to $8.38, a stock in persistent retreat, and the most compelling development is not the short book but who is…
Samsung Electronics heads into its October 28 earnings print with the lending market almost entirely disinterested in its stock and the Street sitting at one of the widest bull-side gaps it has seen all year. The…
VALE3 has dropped 11.4% over the past month to BRL 69.61, its sharpest compression in recent months, arriving at a setup where cheap multiples meet deteriorating earnings momentum ahead of an October 29 result. The…
NICE has reversed sharply from the 13% surge flagged in last week's note, falling 6.7% over the past five sessions to ILS 333.1, with a 3.4% drop on Tuesday alone erasing a chunk of the prior rally. The retreat puts…
Taiwan Semiconductor Manufacturing Company heads into its October 15 Q3 results with short sellers largely absent, borrow costs drifting lower, and the market focused almost entirely on what the 2nm ramp means for…
Airbus SE closes out September down 6% on the month, lagging most of its aerospace peers in a week where the borrow-cost spike that dominated last week's note has fully unwound. The most notable development in the…
GSK heads into its October 28 results on the back foot, down 2.6% over the past week to 1856p, while the broader European pharma group has been mixed and litigation uncertainty continues to hang over the stock. The…
AstraZeneca heads into its October 30 results with the most newsworthy development of the week sitting in the insider register, not the lending market. Chief Executive Pascal Soriot bought 60,000 shares on September 14…
Short sellers have moved aggressively into ELV over the past month, even as the broader lithium peer group posts its own weekly losses, creating a stock-specific pressure story that stands apart from sector noise. The…
Celanese enters October with a stock near multi-year lows, a cluster of insider purchases at current prices, and short sellers adding back positions they cut aggressively through August. The tension between those two…
Digital Realty Trust heads into its October 29 earnings report with a curious split: the stock has lost nearly 5% over the past week, yet both short sellers and options traders have grown less bearish, not more. The…
FXI, the iShares China Large-Cap ETF, heads into the end of September with bears continuing their slow withdrawal from what was, just six weeks ago, one of the most extreme short positions in the ETF market. The…
GOOGL heads into the final trading day of September down 2.9% on the week, at $340.92, with short interest rebuilt at elevated levels and options traders leaning more bullish than they have in a year. The short book…
WLK enters the final stretch of Q3 with a stock down 16% over the past month, a consensus price target sitting well above the current price, and a flurry of analyst cuts that signal the Street is still working through…
Salesforce closes out September with short sellers reversing course sharply, erasing the covering trend noted just a week ago and pushing the stock to its worst monthly performance in recent memory. The short rebuild…
Alnylam Pharmaceuticals heads into its October 29 earnings report with short interest climbing steadily for the past month and the Street divided on where the stock goes next, while the company trades roughly a third…
